Antibody response in Hodgkin's disease and other lymphomas related to HL-A antigens, immunoglobulin levels and therapy.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000917:Antibody Formation / Q000187:drug effects / Q000528:radiation effects; D003168:Complement Fixation Tests; D006385:Hemagglutination Inhibition Tests; D006649:Histocompatibility Antigens; D006689:Hodgkin Disease / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D007072:Immunoglobulin D / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis*; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000276:immunology; D008223:Lymphoma / Q000188:drug therapy / Q000276:immunology* / Q000532:radiotherapy; D011241:Prednisone / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D006649:Histocompatibility Antigens; D007070:Immunoglobulin A; D007072:Immunoglobulin D; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D007252:Influenza Vaccines; D011241:Prednisone